Save time and get answers to complex questions with AI chat
Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expirationOzempic jordan price 2026Nicardipine brand names
See the DrugPatentWatch profile for Cerezyme
Cerezyme (imiglucerase) was approved by the U.S. Food and Drug Administration (FDA) on June 8, 1994. [1]
Cerezyme is an enzyme replacement therapy used for Gaucher disease. [1]
The FDA’s drug approval information (including the approval date) is listed in the product’s FDA records. [1]
Other Questions About Cerezyme :